Study of Bortezomib in Combination With Cyclophosphamide and Rituximab
Clinical trial NCT00958256 · COMPLETED
Trial details
- NCT number
- NCT00958256
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2014-03-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.